IL2 and neoplasm: In all groups where electrotransfer of plasmids IL-2 (EP1 pIL-2), IL-12 (EP1 pIL-12), and their combination (EP1 COMB) was performed, a delay in tumour growth was observed compared to control groups (without treatment and treatment with EP or plasmids only).